Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S.

Mol Ther Nucleic Acids · 2025 · PMC11889396 · PMID 40060931

Europe PMC DOI

hedged sentence

0.0708

closest p · 1.4× alpha

0.0708

boldest claim

The sentences

near significancep value = 0.0708so close (0.05 < p ≤ 0.1)

There is a significant improvement in Dosing Cohort 2 systems dosed with 1 μM VCA-894A on day 14, with near significance by day 20 ( p value = 0.0708).

also in 127 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.